Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86


Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.

Torisson G, van Westen D, Stavenow L, Minthon L, Londos E.

BMC Geriatr. 2015 Jun 16;15:65. doi: 10.1186/s12877-015-0066-4.


Solitary living in Alzheimer's disease over 3 years: association between cognitive and functional impairment and community-based services.

Wattmo C, Londos E, Minthon L.

Clin Interv Aging. 2014 Nov 14;9:1951-62. doi: 10.2147/CIA.S71709. eCollection 2014.


Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.

Wattmo C, Londos E, Minthon L.

BMC Neurol. 2014 Sep 10;14:173. doi: 10.1186/s12883-014-0173-4.


Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study.

Stubendorff K, Larsson V, Ballard C, Minthon L, Aarsland D, Londos E.

BMJ Open. 2014 Jul 3;4(7):e005158. doi: 10.1136/bmjopen-2014-005158.


Risk factors that affect life expectancy in Alzheimer's disease: a 15-year follow-up.

Wattmo C, Londos E, Minthon L.

Dement Geriatr Cogn Disord. 2014;38(5-6):286-99. doi: 10.1159/000362926. Epub 2014 Jul 3.


Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

Hansson O, Hall S, Ohrfelt A, Zetterberg H, Blennow K, Minthon L, Nägga K, Londos E, Varghese S, Majbour NK, Al-Hayani A, El-Agnaf OM.

Alzheimers Res Ther. 2014 May 7;6(3):25. doi: 10.1186/alzrt255. eCollection 2014.


Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.

Bras J, Guerreiro R, Darwent L, Parkkinen L, Ansorge O, Escott-Price V, Hernandez DG, Nalls MA, Clark LN, Honig LS, Marder K, Van Der Flier WM, Lemstra A, Scheltens P, Rogaeva E, St George-Hyslop P, Londos E, Zetterberg H, Ortega-Cubero S, Pastor P, Ferman TJ, Graff-Radford NR, Ross OA, Barber I, Braae A, Brown K, Morgan K, Maetzler W, Berg D, Troakes C, Al-Sarraj S, Lashley T, Compta Y, Revesz T, Lees A, Cairns N, Halliday GM, Mann D, Pickering-Brown S, Dickson DW, Singleton A, Hardy J.

Hum Mol Genet. 2014 Dec 1;23(23):6139-46. doi: 10.1093/hmg/ddu334. Epub 2014 Jun 27.


Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.

Wennström M, Nielsen HM, Orhan F, Londos E, Minthon L, Erhardt S.

Int J Tryptophan Res. 2014 Apr 28;7:1-7. doi: 10.4137/IJTR.S13958. eCollection 2014.


Lack of orthostatic symptoms in dementia patients with orthostatic hypotension.

Bengtsson-Lindberg M, Larsson V, Minthon L, Wattmo C, Londos E.

Clin Auton Res. 2015 Apr;25(2):87-94. doi: 10.1007/s10286-014-0244-z. Epub 2014 Apr 18.


Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies.

Wesnes KA, Aarsland D, Ballard C, Londos E.

Int J Geriatr Psychiatry. 2015 Jan;30(1):46-54. doi: 10.1002/gps.4109. Epub 2014 Apr 16.


Low levels of soluble NG2 in cerebrospinal fluid from patients with dementia with Lewy bodies.

Nielsen HM, Hall S, Surova Y, Nägga K, Nilsson C, Londos E, Minthon L, Hansson O, Wennström M.

J Alzheimers Dis. 2014;40(2):343-50. doi: 10.3233/JAD-132246.


Multidisciplinary intervention reducing readmissions in medical inpatients: a prospective, non-randomized study.

Torisson G, Minthon L, Stavenow L, Londos E.

Clin Interv Aging. 2013;8:1295-304. doi: 10.2147/CIA.S49133. Epub 2013 Sep 26.


Dysphagia in Lewy body dementia - a clinical observational study of swallowing function by videofluoroscopic examination.

Londos E, Hanxsson O, Alm Hirsch I, Janneskog A, Bülow M, Palmqvist S.

BMC Neurol. 2013 Oct 7;13:140. doi: 10.1186/1471-2377-13-140.


Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders.

Nutu M, Zetterberg H, Londos E, Minthon L, Nägga K, Blennow K, Hansson O, Ohrfelt A.

Dement Geriatr Cogn Disord. 2013;36(1-2):99-110. doi: 10.1159/000353442. Epub 2013 Jul 9.


A longitudinal study of risk factors for community-based home help services in Alzheimer's disease: the influence of cholinesterase inhibitor therapy.

Wattmo C, Paulsson E, Minthon L, Londos E.

Clin Interv Aging. 2013;8:329-39. doi: 10.2147/CIA.S40087. Epub 2013 Mar 20.


Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias.

Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E.

Am J Geriatr Psychiatry. 2014 Jun;22(6):580-6. doi: 10.1016/j.jagp.2012.11.001. Epub 2013 Apr 9.


A longitudinal study of physical function in patients with early-onset dementia.

Tangen GG, Londos E, Olsson J, Minthon L, Mengshoel AM.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2(1):622-31. doi: 10.1159/000345782. Epub 2012 Dec 13.


No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias.

Creese B, Ballard C, Aarsland D, Londos E, Sharp S, Jones E.

Neurosci Lett. 2012 Nov 30;531(1):1-4. doi: 10.1016/j.neulet.2012.09.062. Epub 2012 Oct 13. Erratum in: Neurosci Lett. 2014 Sep 19;580:178.


The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia.

Stubendorff K, Aarsland D, Minthon L, Londos E.

PLoS One. 2012;7(10):e45451. doi: 10.1371/journal.pone.0045451. Epub 2012 Oct 1.


Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.

Hall S, Öhrfelt A, Constantinescu R, Andreasson U, Surova Y, Bostrom F, Nilsson C, Håkan W, Decraemer H, Någga K, Minthon L, Londos E, Vanmechelen E, Holmberg B, Zetterberg H, Blennow K, Hansson O.

Arch Neurol. 2012 Nov;69(11):1445-52.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk